Retour aux projets

27582.1 PFLS-LS

Development of a patent non-infringing synthesis of a recently approved API for cancer treatment

Résumé

Development of a patent non-infringing synthesis of a recently approved API for cancer treatment

Textes supplémentaires

Abstract

This proposal includes the development of a new, non-IP protected and economically attractive synthesis of a recently approved API (Active Pharmaceutical Ingredient) and provides a (non-IP infringing) route to a cost-effective manufacturing of the API that is safe, controllable and scalable.

Participants

Roman Gerber

Wirtschaftspartner

rgerber@azad.ch

AZAD Pharma AG CHE-110.166.192 Roman Gerber Durachstrasse 15 8200 Schaffhausen SH CH

Christian Frech Nabold

Kontaktperson

freh@zhaw.ch

ZHAW Christian Frech Nabold Einsiedlerstrasse 31a 8820 Wädenswil ZH CH

Détails du projet

Office de recherche
INNOSUISSE
Statut du projet
Abgeschlossen
Type de projet
Forschungsprojekt
Date de début
2018-03-31
Date de fin
2021-01-31
Coûts totaux approuvés
CHF 785945.00
Section
20 Förderbereich Life Sciences
Domaine politique NABS
Industrielle Produktivität und Technologie

Disciplines de recherche

  • T490 Biotechnology 100.0%